Reading Time: < 1 minute
Dr. Rasheeta Chandler is a researcher at Emory University, who specializes in women’s sexual and reproductive health. In a small recent study, Chandler learned that 67 percent of college-age black women had never heard of the HIV prevention drug PrEP.
In 2013, not quite a year after the Food and Drug Administration approved the drug Truvada for HIV prevention, a coalition of 50 experts in HIV and women’s health called on U.S. public health agencies to promote the pill and its approach, called pre-exposure prophylaxis, or PrEP, explicitly to women. Read More